Zobrazeno 1 - 10
of 177
pro vyhledávání: '"Sherif M. Badawy"'
Publikováno v:
Current Oncology, Vol 30, Iss 1, Pp 720-748 (2023)
Acute lymphoblastic leukemia (ALL) is the most common malignancy in children and young adults. Treatment is long and involves 2–3 years of a prolonged maintenance phase composed of oral chemotherapies. Adherence to these medications is critical to
Externí odkaz:
https://doaj.org/article/92b2dc03e50b403a8b25893338a0d844
Publikováno v:
Annals of Medicine, Vol 54, Iss 1, Pp 326-342 (2022)
Introduction Iron chelation therapy (ICT) is essential to prevent complications of iron overload in patients with transfusion-dependent thalassaemia. However, there is currently no standard for how to best measure adherence to ICT, nor what level of
Externí odkaz:
https://doaj.org/article/d443f16832a64cf8b2b05d68b1675bf5
Publikováno v:
Annals of Medicine, Vol 54, Iss 1, Pp 683-693 (2022)
Background Sickle cell disease (SCD) results in severe complications, such as anaemia and pain episodes. Hydroxyurea (HU) is efficacious in SCD, yet adherence remains low.Objective To assess the relationship of HU adherence to health care utilization
Externí odkaz:
https://doaj.org/article/6818f56895e44d33bdf2d0264438b792
Publikováno v:
Pediatric Hematology Oncology Journal, Vol 7, Iss 4, Pp 116-118 (2022)
May-Thurner syndrome is an uncommon cause of lower extremity deep venous thrombi caused by compression of the left iliac vein in between the right iliac artery and the vertebrae that results in venous insufficiency. This case report describes an adol
Externí odkaz:
https://doaj.org/article/8daa8361f9a14514bf9d9f0028a98c20
Autor:
Guru Subramanian Guru Murthy, Soyoung Kim, Noel Estrada-Merly, Muhammad Bilal Abid, Mahmoud Aljurf, Amer Assal, Talha Badar, Sherif M. Badawy, Karen Ballen, Amer Beitinjaneh, Jan Cerny, Saurabh Chhabra, Zachariah DeFilipp, Bhagirathbhai Dholaria, Miguel Angel Diaz Perez, Shatha Farhan, Cesar O. Freytes, Robert Peter Gale, Siddhartha Ganguly, Vikas Gupta, Michael R. Grunwald, Nada Hamad, Gerhard C. Hildebrandt, Yoshihiro Inamoto, Tania Jain, Omer Jamy, Mark Juckett, Matt Kalaycio, Maxwell M. Krem, Hillard M. Lazarus, Mark Litzow, Reinhold Munker, Hemant S. Murthy, Sunita Nathan, Taiga Nishihori, Guillermo Ortí, Sagar S. Patel, Marjolein van der Poel, David A. Rizzieri, Bipin N. Savani, Sachiko Seo, Melhem Solh, Leo F. Verdonck, Baldeep Wirk, Jean A. Yared, Ryotaro Nakamura, Betul Oran, Bart Scott, Wael Saber
Publikováno v:
Haematologica, Vol 108, Iss 7 (2023)
Allogeneic hematopoietic cell transplantation (allo-HCT) remains the only curative treatment for myelofibrosis. However, the optimal conditioning regimen either with reduced-intensity conditioning (RIC) or myeloablative conditioning (MAC) is not well
Externí odkaz:
https://doaj.org/article/3607fa3e9937487db3f85032af240a0d
Autor:
Sherif M. Badawy, Amanda B. Payne
Publikováno v:
Blood Advances, Vol 3, Iss 21, Pp 3297-3306 (2019)
Abstract: Metformin was recently found to increase fetal hemoglobin, which is protective in sickle cell disease (SCD). We tested the hypothesis that, among adults with SCD and diabetes mellitus (DM), metformin use is associated with fewer adverse SCD
Externí odkaz:
https://doaj.org/article/e8cb0ae391554265a46b0defcdb43a8f
Publikováno v:
Pharmacy, Vol 10, Iss 5, p 123 (2022)
Sickle-cell disease (SCD) is an inherited hemoglobinopathy, causing lifelong complications such as painful vaso-occlusive episodes, acute chest syndrome, stroke, chronic anemia, and end-organ damage, with negative effects on quality of life and life
Externí odkaz:
https://doaj.org/article/b81083e827fb43d7bd3cedb3fde41809
Autor:
Nelli Bejanyan, Soyoung Kim, Kyle M. Hebert, Natasha Kekre, Hisham Abdel-Azim, Ibrahim Ahmed, Mahmoud Aljurf, Sherif M. Badawy, Amer Beitinjaneh, Jaap Jan Boelens, Miguel Angel Diaz, Christopher C. Dvorak, Shahinaz Gadalla, James Gajewski, Robert Peter Gale, Siddhartha Ganguly, Andrew R. Gennery, Biju George, Usama Gergis, David Gómez-Almaguer, Marta Gonzalez Vicent, Hasan Hashem, Rammurti T. Kamble, Kimberly A. Kasow, Hillard M. Lazarus, Vikram Mathews, Paul J. Orchard, Michael Pulsipher, Olle Ringden, Kirk Schultz, Pierre Teira, Ann E. Woolfrey, Blachy Dávila Saldaña, Bipin Savani, Jacek Winiarski, Jean Yared, Daniel J. Weisdorf, Joseph H. Antin, Mary Eapen
Publikováno v:
Blood Advances, Vol 3, Iss 20, Pp 3123-3131 (2019)
Abstract: Allogeneic bone marrow transplantation (BMT) is curative therapy for the treatment of patients with severe aplastic anemia (SAA). However, several conditioning regimens can be used for BMT. We evaluated transplant conditioning regimens for
Externí odkaz:
https://doaj.org/article/5355366127ff44c8b0ec931af3a7f734
Autor:
Keira Nassetta, Tasmeen Hussain, Katheryn Gambetta, Kevin Le, Linda C. O’Dwyer, Sherif M. Badawy
Publikováno v:
Journal of Cardiovascular Development and Disease, Vol 9, Iss 5, p 165 (2022)
After pediatric heart transplant, commitment to lifelong immunosuppression is crucial to maintaining graft health. However, a review of the current literature surrounding adherence to immunosuppression in pediatric heart transplant patients is lackin
Externí odkaz:
https://doaj.org/article/9e9c438367ba4120b1c96d8451fc9683
Publikováno v:
Journal of Cardiovascular Development and Disease, Vol 8, Iss 6, p 68 (2021)
Society and medical practice have been restructured dramatically to avoid further spread of the COVID-19 virus; telehealth/telemedicine, mask wearing, and nationwide social distancing practices have become widespread. However, we still face unprecede
Externí odkaz:
https://doaj.org/article/3bdfcf2dcbe44cbfb8277c60d12b29f1